Ratan Tata to lay foundations for a 300 bed cancer hospital in Ranchi

Ratan Tata, the chairman emeritus of Tata Sons and the chairman of Tata Trusts, will lay the foundations for a the hospital cum research center on Saturday.

The hospital will come up on 23 acres of land donated by the state department of health, medical education and family welfare department to the Tata Trusts in Kanke on the outskirts of the state capital earlier this year.

Jharkhand health secretary Nitin Madan Kulkarni said the first phase of the hospital is expected to become operational with 150 beds by 2022. “Once operational, it will cater to thousands of cancer patients of Jharkhand who visit different states for treatment every year,” Kulkarni added.

The groundbreaking comes less than a week before Jharkhand is due to observe the 18th statehood day.

State government had said seeds of the hospital were sown during the inaugural session of the Momentum Jharkhand Global Investment Summit held in February 2017 when Jharkhand chief minister Raghubar Das approached Tata and floated the idea of building a cancer care center, which the latter agreed to.

With Jharkhand lacking a robust cancer treatment infrastructure in its state run tertiary and secondary healthcare centers, the health department has approached the Tata Trusts to handhold in setting up screening facilities in government healthcare centers.

  • Related Posts

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    Healthy Heart is a Misnomer until underpinned by Regular Screening Bangaluru/ New Delhi: Of late, heart health has become kind of a veritable conundrum. We were never so unsure of…

    Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

    The aim is to encourage adolescents and antenatal women to undergo timely thalassemia screening New Delhi: The Ministry of Health and Family Welfare unveiled two awareness posters on thalassemia screening…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’